- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT00305513
Effectiveness of Rehabilitation on the Recovery of Patients Post Right Stroke With Unilateral Spatial Neglect
Effectiveness of Rehabilitation (Phasic Alerting and Visual Spatial Scanning Training) on the Recovery of Patients Post Right Stroke With Unilateral Spatial Neglect: Using Functional Imaging PET and Standardized Neurobehavioral and Functional Tests
Unilateral spatial neglect (USN) is believed to be a disorder of attention, characterized by impairment in the ability to perceive or respond to stimuli presented to the contralesional space, and which is not attributable to significant sensory or motor deficits. USN has serious consequences for rehabilitation and long term disabilities. Efforts have been made to clarify both the theoretical basis of this phenomenon and the rehabilitation methods that will be best in improving function. The purpose of this study is to try and contribute to both efforts by examining treatment effectiveness of two methods; one targeting general arousal (phasic alerting), and the other targeting increasing awareness to left side stimuli and habit changes. Functional neuroimaging methods (PET [positron emission tomography] and fMRI [functional magnetic resonance imaging]) have been applied to understand the functional anatomy of the brain during mental processes. Only a few attempts have been made to use functional neuroimaging in patients with neurological deficits such as USN, usually speculations are made based on findings with healthy participants to explain this disorder. This study's aim is to examine the functional reorganization of the attentional network in the brain of USN patients while performing visual tasks, by means of functional neuroimaging techniques, in light of specific rehabilitation techniques.
Patients will be examined before and after 3 weeks of rehabilitation both using standardized neurobehavioral tests and PET imaging procedures.
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Procedure:
Inclusion criteria:
- first time right hemispheric stroke (ischemic);
- 2-6 weeks post stroke incident;
- ages 25-85;
- right hand dominance;
- minimum education of 6 years;
- do not suffer from field cut deficit such as hemi-anopsia;
- without other known neurological disorders (e.g., Parkinson's disease, aphasia);
- without severe systemic conditions (e.g., malignancies, AIDS, congestive heart failure, substance abuse);
- did not take additional medications that could affect the central nervous system; without dementia;
- without mental illness;
- the patients or their legal guardians have to give informed consent.
Participants:
- six patients will be recruited and randomly allocated to one of the treatment groups (phasic alerting or standard visual spatial training treatment provided in the OT department).
Patients will undergo thorough evaluation of neglect and will undergo PET procedure before being transferred to rehabilitation. Patient will receive intensive rehabilitation for 15 sessions of the cognitive treatment and 15 session of motor training. After this period patient will undergo another PET procedure to assess any changes in brain activation. Patient will then return to rehabilitation as needed.
Study Type
Enrollment (Anticipated)
Phase
- Phase 2
Contacts and Locations
Study Contact
- Name: Zeev Meiner, MD
- Phone Number: 00 972 2 5844582
- Email: MEINER@hadassah.org.il
Study Locations
-
-
-
Jerusalem, Israel, 91120
- Hadassah Medical Organization
-
Principal Investigator:
- Zeev Meiner, MD
-
Principal Investigator:
- Roland Chishin, MD
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- First time right hemispheric stroke (ischemic)
- 2 - 6 weeks post stroke incident
- Ages 25 - 85
- Right hand dominance
- Minimum education of 6 years
- The patients or their legal guardians have to give informed consent
- Does not suffer from field cut deficit such as hemi-anopsia
- Without other known neurological disorders (e.g., Parkinson's disease, aphasia)
- Without severe systemic conditions (e.g., malignancies, AIDS, congestive heart failure, substance abuse)
- Does not take additional medications that could affect the central nervous system
- Without dementia
- Without mental illness
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
---|
This study's aim is to examine the functional reorganization of the attentional network in the brain of USN patients while performing visual tasks, by means of functional neuroimaging techniques, in light of specific rehabilitation techniques.
|
Secondary Outcome Measures
Outcome Measure |
---|
The aim of this study is to try and contribute to both efforts by examining treatment effectiveness of two methods; one targeting general arousal (phasic alerting), and the other targeting increasing awareness to left side stimuli and habit changes.
|
Collaborators and Investigators
Sponsor
Investigators
- Principal Investigator: Zeev Meiner, MD, Hadassah Medical Organization
Study record dates
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Estimate)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
- Cardiovascular Diseases
- Vascular Diseases
- Cerebrovascular Disorders
- Brain Diseases
- Central Nervous System Diseases
- Nervous System Diseases
- Neurologic Manifestations
- Neurobehavioral Manifestations
- Stroke
- Perceptual Disorders
- Physiological Effects of Drugs
- Neurotransmitter Agents
- Molecular Mechanisms of Pharmacological Action
- Enzyme Inhibitors
- Purinergic Antagonists
- Purinergic Agents
- Phosphodiesterase Inhibitors
- Purinergic P1 Receptor Antagonists
- Central Nervous System Stimulants
- Caffeine
Other Study ID Numbers
- 10-17.02.06-HMO-CTIL
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Perceptual Disorders
-
Integrative Psychiatry InstituteNot yet recruitingPsychedelic Experiences | Therapeutic Alliance | Psychology, Perceptual
-
University of California, IrvineNational Institute on Aging (NIA)RecruitingAging | Auditory Perceptual ImpairmentUnited States
-
National Institute on Deafness and Other Communication...TerminatedLanguage Delay | Language Disorder | Auditory Perceptual DisorderUnited States
-
National Institute on Deafness and Other Communication...TerminatedEpilepsy | Hearing Disorder | Intracranial Central Nervous System Disorder | Brain Mapping | Auditory Perceptual DisorderUnited States
-
Florida State UniversityUnited States Department of Defense; Southeast Louisiana Veterans Health Care...Completed
-
VA Office of Research and DevelopmentNot yet recruitingAuditory Processing DisorderUnited States
-
University of ArkansasCompletedAuditory Processing DisorderUnited States
-
University College, LondonGN ResoundCompletedAuditory Processing Disorder
-
Children's Hearing Evaluation and Amplification...UnknownAuditory Processing DisorderUnited Kingdom
-
University Hospital MuensterPhonak AG, SwitzerlandUnknownAuditory Processing DisorderGermany, Switzerland
Clinical Trials on The phasic alerting treatment
-
University of OttawaCompleted
-
Jieming QUCompleted
-
Peking Union Medical CollegeThe Second Affiliated Hospital of Harbin Medical UniversityCompletedColorectal Cancer | Lung Metastases
-
Abbott Medical DevicesTerminated
-
EXcorLab GmbHNipro Europe N.V.CompletedChronic Kidney DiseaseBelgium
-
Centre Hospitalier Universitaire de NiceCompletedChronic Kidney DiseaseFrance
-
Peking Union Medical CollegeChanghai Hospital; The Second Affiliated Hospital of Harbin Medical UniversityCompleted
-
University of ValenciaCompleted
-
Centre Hospitalier de TroyesInstitut National de la Santé Et de la Recherche Médicale, FranceNot yet recruitingOSTEOPATHY IN THE TREATMENT OF IBS SYMPTOMS IN ADULTS
-
Dokuz Eylul UniversityRecruitingSports Physical TherapyTurkey